Stay updated on Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial

Sign up to get notified when there's something new on the Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    No significant changes were detected between the two screenshots; the page content and layout appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:22:56.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Core content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:52:50.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.
    Difference
    0.5%
    Check dated 2025-09-29T03:10:41.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.3%
    Check dated 2025-09-14T19:55:58.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-07T16:59:25.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to drug safety and specific medical conditions. Notably, the previous version's references to certain immunologic factors and location details have been removed.
    Difference
    2%
    Check dated 2025-08-31T12:15:45.000Z thumbnail image

Stay in the know with updates to Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial page.